Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closed to Accrual

MAC.7 (SWOG S0226) -- Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant
as First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer -- was closed to accrual on 1 July 2009.

MAC.7 has reached its target.

http://www.ctg.queensu.ca/trials/breast/mac7/mac7.html